Skip to main content

Table 1 Selected Demographic and Baseline Characteristics

From: The effects of antiretroviral therapy initiation time on HIV reservoir size in Chinese chronically HIV infected patients: a prospective, multi-site cohort study

 

DIG(N = 265)

EIG(N = 179)

P value

Age: years (IQR)

33(27–42)

32(27–40)

0.276

Male: no. (%)

199(75.1)

125 (69.8)

0.232

Ethnicity:no. (%)

 Han

195(73.6)

123(68.1)

0.284

 Other

70 (26.4)

56 (31.9)

 

Mode of HIV acquisition: no. (%)

 MSM

92 (34.7%)

63 (35.2%)

0.920

  Heterosexual

142 (53.6%)

98 (54.7%)

0.846

  Bisexual

6 (2.3%)

6 (3.4%)

0.557

  Blood products

2 (0.4%)

1 (0.6%)

1.000

  Other/undefined

14 (9.3%)

11 (5.5%)

0.682

HIV-1 subtype

 AE

125 (47.2%)

60 (33.5%)

0.004

 B/C/BC

69 (26.0%)

63 (35.2%)

0.044

  unknown

71 (26.8%)

56 (31.3%)

0.336

CD4 count: (cells/mm3)

239 (161–292)

401 (376–451)

< 0.001

CD4/CD8 ratio:

0.25 (0.19–0.39)

0.39 (0.24–0.45)

0.001

HIV-1 RNA: (log10 copies/mL)

4.83 (4.43–5.14)

4.66 (4.39–5.05)

0.641

HIV-1 DNA: (log10 copies /106PBMCs)

3.00 (2.65–3.39)

2.73 (2.40–3.03)

< 0.001

HBsAg (+): no. (%)

27 (10.2%)

18 (10.1%)

1.000

HCV-Ab (+): no. (%)

9 (3.4%)

4 (2.2%)

0.579

  1. Data are number (%) or median (IQR). MSM: men who have sex with men; DIG: delayed initiation group; EIG: early initiation group; HIV: human immunodeficiency virus; IQR: interquartile range; PBMC: peripheral mononuclear cell; HBsAg: Hepatitis B surface antigen; HCV: Hepatitis C virus; Ab: antibody